These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features. Moneta GM, Pires Marafon D, Marasco E, Rosina S, Verardo M, Fiorillo C, Minetti C, Bracci-Laudiero L, Ravelli A, De Benedetti F, Nicolai R. Arthritis Rheumatol; 2019 Jun; 71(6):1011-1021. PubMed ID: 30552836 [Abstract] [Full Text] [Related]
4. Comparison between treatment naive juvenile and adult dermatomyositis muscle biopsies: difference of inflammatory cells phenotyping. Shinjo SK, Sallum AME, Oba-Shinjo SM, Silva MG, Silva CA, Marie SKN. Adv Rheumatol; 2018 Oct 26; 58(1):37. PubMed ID: 30657098 [Abstract] [Full Text] [Related]
7. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy. Das L, Blumbergs PC, Manavis J, Limaye VS. Appl Immunohistochem Mol Morphol; 2013 Dec 26; 21(6):539-42. PubMed ID: 23343957 [Abstract] [Full Text] [Related]
9. Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue. Englund P, Nennesmo I, Klareskog L, Lundberg IE. Arthritis Rheum; 2002 Apr 26; 46(4):1044-55. PubMed ID: 11953983 [Abstract] [Full Text] [Related]
10. Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis. Gitiaux C, De Antonio M, Aouizerate J, Gherardi RK, Guilbert T, Barnerias C, Bodemer C, Brochard-Payet K, Quartier P, Musset L, Chazaud B, Desguerre I, Bader-Meunier B. Rheumatology (Oxford); 2016 Mar 26; 55(3):470-9. PubMed ID: 26424834 [Abstract] [Full Text] [Related]
11. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis. Preuße C, Allenbach Y, Hoffmann O, Goebel HH, Pehl D, Radke J, Doeser A, Schneider U, Alten RH, Kallinich T, Benveniste O, von Moers A, Schoser B, Schara U, Stenzel W. Acta Neuropathol Commun; 2016 Apr 27; 4(1):45. PubMed ID: 27121733 [Abstract] [Full Text] [Related]
13. Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126. Kim E, Cook-Mills J, Morgan G, Sredni ST, Pachman LM. Arthritis Rheum; 2012 Nov 27; 64(11):3809-17. PubMed ID: 22740338 [Abstract] [Full Text] [Related]
14. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourré-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Senécal JL. Medicine (Baltimore); 2014 Nov 27; 93(24):318-332. PubMed ID: 25500701 [Abstract] [Full Text] [Related]
15. Respiratory chain dysfunction in perifascicular muscle fibres in patients with dermatomyositis is associated with mitochondrial DNA depletion. Hedberg-Oldfors C, Lindgren U, Visuttijai K, Lööf D, Roos S, Thomsen C, Oldfors A. Neuropathol Appl Neurobiol; 2022 Dec 27; 48(7):e12841. PubMed ID: 35894812 [Abstract] [Full Text] [Related]